| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |